REFERENCES
1. Rosario NA, Riedi CA. Cystic fibrosis and atopy. Allergol
Immunopathol. 2013;41(2):137-139.
2. Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors.
Semin Immunopathol. 2020;42(1):5-15.
3. Antunes J, Fernandes A, Miguel Borrego L, Leiria-Pinto P, Cavaco J.
Cystic fibrosis, atopy, asthma and ABPA. Allergol Immunopathol.
2010;38:278-84.
4. Brand PLP. Bronchodilators in cystic fibrosis. J R Soc Med.
2000;93(38):37–9.
5. Janahi IA, Rehman A, Al-Naimi AR. Allergic bronchopulmonary
aspergillosis in patients with cystic fibrosis. Ann Thorac Med.
2017;12(2):74-82.
6. Collaco JM, Morrow CB, Green DM, Cutting GR, Mogayzel PJ Jr.
Environmental allergies and respiratory morbidities in cystic fibrosis.
Pediatr Pulmonol. 2013;48(9):857-64.
7. Warner JO, Kilburn SA. Cystic fibrosis and allergy. Pediatr Allergy
Immunol. 1996;7(9):67–9.
8. Silverman M, Hobbs FD, Gordon IR, Carswell F. Cystic fibrosis, atopy,
and airways lability. Arch Dis Child. 1978;53(11):873-7.
9. Moustaki M, Loukou I, Tsabouri S, Douros K. The Role of Sensitization
to Allergen in Asthma Prediction and Prevention. Front Pediatr.
2017;5:166.
10. Pitcher-Wilmott RW, Levinsky RJ, Gordon I, Turner MW, Matthew DJ.
Pseudomonas infection, allergy, and cystic fibrosis. Arch Dis Child.
1982;57(8):582–6.
11. Farrell PM, Rosenstein BJ, White TB, et al. Cystic Fibrosis
Foundation. Guidelines for diagnosis of cystic fibrosis in newborns
through older adults: Cystic Fibrosis Foundation consensus report. J
Pediatr. 2008;153(2):4-14.
12. Just J, Deslandes‐Boutmy E, Amat F, Desseaux K, Nemni A, Bourrat E,
et al. Natural history of allergic sensitization in infants with
early‐onset atopic dermatitis: results from ORCA Study. Pediatr Allergy
Immunol. 2014;25(7):668-673.
13.Tu YL, Chang SW, Tsai HJ, Chen LC, Lee WI, Hua MC, Cheng JH, Ou LS,
Yeh KW, Huang JL,et al; PATCH study group. Total serum IgE in a
population-based study of Asian children in Taiwan: reference value and
significance in the diagnosis of allergy. PLoS One. 2013;8(11):80996.
14. Doershuk C, Mathews L, Tucker A. A five year clinical evaluation for
a therapeutic program for patients with cystic fibrosis. J Pediatr.
1964;65:677-693.
15. Alishbayli G, Kilinc AA, Cokugras H. Evaluation of the
health-related quality of life in Turkish cystic fibrosis patients.
Pediatr Int. 2021;63(8):965-970.
16. Wang X, Dockery DW, Wypij D, Gold DR, Speizer FE, Ware JH, Ferris BG
Jr. Pulmonary function growth velocity in children 6 to 18 years of age.
Am Rev Respir Dis. 1993;148:1502‐1508.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values
from a sample of the general US population. Am J Respir Crit Care Med.
1999;159:179‐187.
18. Royal Brompton Hospital paediatric CF
team. Clinical Guidelines: Care of Children with Cystic Fibrosis, 2020
[8th Eds:[Available from: www.rbht.nhs.uk/childrencf].
19. Green DM, McDougal KE, Blackman SM, Sosnay PR, Henderson LB,
Naughton KM, Collaco JM, Cutting GR. Mutations that permit residual CFTR
function delay acquisition of multiple respiratory pathogens in CF
patients. Respir Res. 2010;11(1):140.
20. Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the
diagnosis and treatment of allergic bronchopulmonary
aspergillosis. Expert Rev Respir Med. 2016;10(12):1317-1334.
21. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A,
Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al; World
HealthOrganization; GA(2)LEN; Allergen. Allergic Rhinitisandits ımpact
on Asthma (ARIA) 2008 update. Allergy 2008;63(86):8-160.
22. Weir CB, Jan A. BMI Classification Percentile And Cut Off Points.
2021 May 9. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing.
23. Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR.
Quantification of the relative contribution of environmental and genetic
factors to variation in cystic fibrosis lung function. J Pediatr.
2010;157(5):802–7.
24. Wilmott RW. The relationship between atopy and cystic fibrosis. Clin
Rev Allergy. 1991;9(1-2):29-46.
25. Balfour-Lynn IM, Elborn JS. ”CF asthma”: what is it and what do we
do about it?. Thorax. 2002;57(8):742-748.
26. Karaman O, Turgut CS, Uzuner N, Olmez D, Babayigit A, Kose S, Tezcan
D. The determination of asthma, rhinitis, eczema, and atopy prevalence
in 9- to 11-year-old children in the city of Izmir. Allergy Asthma Proc.
2006;27(4):319-24.
27. Hallstrand TS, Calenoff E, Becker JW, Henderson Jr WR, Aitken ML.
The role of allergy in manifestations of respiratory disease in adult
cystic fibrosis. Ann Allergy Asthma Immunol. 2004;92:228-33.
28. Nikolaizik WH, Moser M, Crameri R, Little S, Warner JO, Blaser K,
Schöni MH. Identification of allergic bronchopulmonary aspergillosis
incystic fibrosis patients by recombinantAspergillus fumigatus
I/a-specific serology. Am J Respir Crit Care Med. 1995;152:634–9.
29. Kent BD, Lane SJ, van Beek EJ, Dodd JD, Costello RW, Tiddens HA.
Asthma and cystic fibrosis: a tangled web. Pediatr Pulmonol.
2014;49(3):205-13.
30. Pabary R. Severe pulmonary exacerbation in cystic fibrosis caused by
cat allergy. Paediatr Respir Rev. 2014;15(1):29-31.
31. SanchezI, PowellRE, PasterkampH. Wheezing and air flow obstruction
during methacholine challenge in children with cystic fibrosis and in
normal children. Am Rev Respir Dis. 1993;147:705–9.
32. Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J,
Mastella G. International practice patterns by age and severity of lung
disease in cystic fibrosis: data from the Epidemiologic Registry of
Cystic Fibrosis (ERCF). Pediatr Pulmonol. 1997;24:147–54.
33. Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ;
Scientific Advisory Group and the Investigators and Coordinators of the
Epidemiologic Study of Cystic Fibrosis. Relationship between inhaled
corticosteroid therapy and rate of lung function decline in children
with cystic fibrosis. J Pediatr. 2008;153(6):746–51.
34. Nikolaizik WH, Schoni MH. Effect of inhaled corticosteroids on lung
function of cystic fibrosis patients – a prospective study. Eur Respir
J. 1994;7:430S.
35. Levine H, Cohen-Cymberknoh M, Klein N, Hoshen M, Mussaffi H, Stafler
P, Breuer O, Kerem E, Blau H. Reversible airway obstruction in cystic
fibrosis: Common, but not associated with characteristics of asthma. J
Cyst Fibros. 2016;15(5):652-9.
36. Calella P, Valerio G, Thomas M, McCabe H, Taylor J, Brodlie M,
Siervo M. Association between body composition and pulmonary function in
children and young people with cystic fibrosis. Nutrition.
2018;48:73-76.